CATALOGO DEI PRODOTTI DELLA RICERCA

Carbognin, Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 985
EU - Europa 929
AS - Asia 394
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 984
GB - Regno Unito 340
CN - Cina 317
SE - Svezia 123
IT - Italia 109
IE - Irlanda 94
FR - Francia 73
DE - Germania 70
RU - Federazione Russa 61
SG - Singapore 32
FI - Finlandia 27
KR - Corea 20
UA - Ucraina 16
JP - Giappone 7
NL - Olanda 6
VN - Vietnam 4
IR - Iran 3
PL - Polonia 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
EU - Europa 1
GR - Grecia 1
IN - India 1
LU - Lussemburgo 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 2.313
Salva come PNG Salva come JPEG
Città #
Southend 328
Chandler 263
Woodbridge 133
Dublin 94
Beijing 83
New York 61
Jacksonville 57
Ann Arbor 44
Ashburn 38
Lawrence 31
Princeton 31
Verona 30
Wilmington 28
Jinan 25
Shenyang 25
Nanjing 23
Tianjin 21
Singapore 20
Seoul 19
Hebei 13
Houston 13
Zhengzhou 12
Sindelfingen 11
Changsha 10
Guangzhou 9
Los Angeles 8
Ningbo 8
Haikou 6
Hangzhou 6
Seattle 6
Taiyuan 6
Markgröningen 5
Milan 5
Nanchang 5
Redmond 5
Redwood City 5
Augusta 4
Cagliari 4
Dearborn 4
Helsinki 4
Lancaster 4
Rome 4
Taizhou 4
Bologna 3
Clearwater 3
Detroit 3
Frankfurt am Main 3
Fremont 3
Jiaxing 3
Kent 3
Mountain View 3
Riva 3
San Mateo 3
Sant'Ambrogio di Valpolicella 3
Tokyo 3
Washington 3
Woodbury 3
Amsterdam 2
Brussels 2
Busto Arsizio 2
Cambridge 2
Dallas 2
Düsseldorf 2
Florence 2
Fuzhou 2
Hamburg 2
Norwalk 2
Paris 2
Pozza 2
Saint Louis 2
San Francisco 2
Sossano 2
Taipei 2
Tashkent 2
Ardabil 1
Athens 1
Austin 1
Baku 1
Bergamo 1
Boardman 1
Boydton 1
Canberra 1
Castelnuovo 1
Changle 1
Chicago 1
Cologne 1
Fairfield 1
Groningen 1
Istanbul 1
Kashan 1
Kochi 1
Lanzhou 1
London 1
Luxembourg 1
Mainz 1
Mehlingen 1
Melbourne 1
Miami 1
Moscow 1
Munich 1
Totale 1.617
Salva come PNG Salva come JPEG
Nome #
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 115
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 105
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 104
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 100
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 99
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 97
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 96
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 91
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 90
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 87
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 85
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 83
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 81
Identification of clinical, pathological and molecular predictors of prognosis in early-stage invasive lobular breast cancer: role of proliferation and CDK4/6 pathway. 79
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research 72
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. 70
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival 69
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 66
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy 65
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment 65
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity 62
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 61
Muscle derangement and alteration of the nutritional machinery in NSCLC 60
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 58
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over? 57
The obesity paradox in cancer: clinical insights and perspectives 57
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer 54
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 53
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option? 47
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis 46
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target. 39
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 29
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 20
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 9
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 8
Totale 2.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.692
article - articoli 8.172
book - libri 0
conference - conferenze 284
curatela - curatele 0
other - altro 236
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 1 9 31 25 38 16 32 19 20 33
2020/2021212 27 37 12 45 24 19 2 2 7 5 26 6
2021/2022269 20 92 0 33 11 3 3 8 13 6 15 65
2022/2023645 36 90 39 134 57 151 3 37 64 1 20 13
2023/2024355 14 24 16 27 54 75 7 32 10 34 55 7
2024/202578 38 33 7 0 0 0 0 0 0 0 0 0
Totale 2.379